Fralex Therapeutics Inc. is dedicated to improving quality of life through the use of neuromodulation therapy. Our technology – known as the Complex Neural Pulse (CNP) – is being developed as a non-drug alternative for the treatment of chronic pain.

Further applications are planned in the treatment of depression and anxiety.

Press Releases

October 2, 2008 Fralex Provides Update On RELIEF Trial

September 25, 2008 Fralex Provides Update On Timing Of Interim Analysis Results

Note: The above documents are in PDF format.